Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 15, 2026, titled "Sun Pharma receives approval to manufacture and market generic semaglutide in South Africa".
Sun Pharmaceutical Industries Limited Press Release Jul 15 2026
Filed with NSE · · 2 pages · English
Release
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- American Skin Association annual gala recognizes Sun Pharma with corporate leadership award
- At the ASCO® 2026 Annual Meeting, Sun Pharma to Present Pivotal Long-Term Follow-up Data on UNLOXCYT™ (cosibelimab-ipdl)
- Press Release May 26 2026
- Sun Pharmaceutical Industries, Inc. (Sun Pharma) Initiates Voluntary U.S. Nationwide Recall of DOXOrubicin Hydrochloride Liposome...
- Sun Pharma To Acquire Organon
Later from Sun Pharmaceutical Industries
- Sun Pharmaceutical Industries Limited Press Release Jul 24 2026
- Sun Pharmaceutical Industries Limited Press Release Jul 29 2026
- Sun Pharmaceutical Industries Limited Press Release Sep 01 2026
- Sun Pharma and Christian Siriano Launch "Regrowth Restyled" to Inspire Adults Living with Severe Alopecia Areata
- First-Ever Standardized U.S. Treatment Recommendations Issued for Adults with Severe Alopecia Areata; Sun Pharma Welcomes Milestone
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries